June 28, 2019
1 min read
Save

Top stories in gastroenterology: Yogurt may reduce risk for precancerous growths in the bowel, budesonide orodispersible tablets maintain eosinophilic esophagitis remission

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The top story in gastroenterology last week was a study that found men who eat at least two servings of yogurt a week could have a reduced risk for developing precancerous growths in the bowel.

The other top stories were from Digestive Disease Week and included a study that found patients who received budesonide orodispersible tablets for the treatment of eosinophilic esophagitis were able to maintain remission through 48 weeks, data that suggested Viberzi controlled gut symptoms in patients with diarrhea-predominant irritable bowel syndrome, a study that determined more choices did not increase the likelihood of participation in colorectal cancer screening programs and findings that indicated nutritional deficiencies impact gastroparesis symptoms.

Yogurt may help prevent precursors of colorectal cancer in men

Men who eat at least two servings of yogurt a week could have a reduced risk for developing precancerous growths in the bowel, according to data published in Gut. Read more.

Budesonide orodispersible tablets maintain eosinophilic esophagitis remission

SAN DIEGO — Patients receiving budesonide orodispersible tablets for the treatment of eosinophilic esophagitis were able to maintain remission through 48 weeks, according to study results presented at Digestive Disease Week. Read more.

Viberzi controls gut symptoms in patients with diarrhea-predominant irritable bowel syndrome

SAN DIEGO — Patients with diarrhea-predominant irritable bowel syndrome who previously had an inadequate response to loperamide therapy were able to achieve symptom control with Viberzi, a speaker said. Read more.

More options do not increase colorectal cancer screening

SAN DIEGO — Presenting individuals with more choices did not increase the likelihood of participation in colorectal cancer screening programs, according to study results. Read more.

Nutritional deficiencies impact gastroparesis symptoms

SAN DIEGO — Patients with gastroparesis who have vitamin, mineral or protein deficiencies, which is about half of patients, are more prone to symptoms of nausea and vomiting, a speaker said. Read more.